The cystic fibrosis transmembrane conductance regulator

Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide

Philip J. Thomas, Ponniah Shenbagamurthi, John Sondek, Joanne M. Hullihen, Peter L. Pedersen

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Deletion of phenylalanine 508 (ΔPhe-508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes approximately 70% of all cases of cystic fibrosis. This residue lies in a region of the protein that we have synthesized chemically and shown to bind adenine nucleotides (Thomas, P. J., Shenbagamurthi, P., Ysern, X., and Pedersen, P. L. (1991) Science 251, 555-557). A peptide lacking this critical residue, but otherwise corresponding to this crucial part of the protein, now also has been chemically synthesized and purified. This mutant peptide (P-66) exhibits a significant loss of β-sheet structure as compared with the wild type peptide (P-67). Furthermore, urea denaturation of peptide structure reveals that P-66 is less stable than P-67. Although under non-denaturing conditions both peptides bind adenine nucleotides with high affinity, the loss of structural stability is reflected in the binding function of the peptides. Thus, P-67, in contrast to P-66, retains a significant capacity for nucleotide binding in 4 M urea. These results suggest a model for impaired ΔPhe-508 CFTR function.

Original languageEnglish (US)
Pages (from-to)5727-5730
Number of pages4
JournalJournal of Biological Chemistry
Volume267
Issue number9
StatePublished - Mar 25 1992

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Cystic Fibrosis
Peptides
Mutation
Adenine Nucleotides
Phenylalanine
Urea
Proteins
Denaturation
Nucleotides
peptide P

ASJC Scopus subject areas

  • Biochemistry

Cite this

The cystic fibrosis transmembrane conductance regulator : Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. / Thomas, Philip J.; Shenbagamurthi, Ponniah; Sondek, John; Hullihen, Joanne M.; Pedersen, Peter L.

In: Journal of Biological Chemistry, Vol. 267, No. 9, 25.03.1992, p. 5727-5730.

Research output: Contribution to journalArticle

@article{5c2a74a3bd7c454abfa0b5967f1989e0,
title = "The cystic fibrosis transmembrane conductance regulator: Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide",
abstract = "Deletion of phenylalanine 508 (ΔPhe-508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes approximately 70{\%} of all cases of cystic fibrosis. This residue lies in a region of the protein that we have synthesized chemically and shown to bind adenine nucleotides (Thomas, P. J., Shenbagamurthi, P., Ysern, X., and Pedersen, P. L. (1991) Science 251, 555-557). A peptide lacking this critical residue, but otherwise corresponding to this crucial part of the protein, now also has been chemically synthesized and purified. This mutant peptide (P-66) exhibits a significant loss of β-sheet structure as compared with the wild type peptide (P-67). Furthermore, urea denaturation of peptide structure reveals that P-66 is less stable than P-67. Although under non-denaturing conditions both peptides bind adenine nucleotides with high affinity, the loss of structural stability is reflected in the binding function of the peptides. Thus, P-67, in contrast to P-66, retains a significant capacity for nucleotide binding in 4 M urea. These results suggest a model for impaired ΔPhe-508 CFTR function.",
author = "Thomas, {Philip J.} and Ponniah Shenbagamurthi and John Sondek and Hullihen, {Joanne M.} and Pedersen, {Peter L.}",
year = "1992",
month = "3",
day = "25",
language = "English (US)",
volume = "267",
pages = "5727--5730",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - The cystic fibrosis transmembrane conductance regulator

T2 - Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide

AU - Thomas, Philip J.

AU - Shenbagamurthi, Ponniah

AU - Sondek, John

AU - Hullihen, Joanne M.

AU - Pedersen, Peter L.

PY - 1992/3/25

Y1 - 1992/3/25

N2 - Deletion of phenylalanine 508 (ΔPhe-508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes approximately 70% of all cases of cystic fibrosis. This residue lies in a region of the protein that we have synthesized chemically and shown to bind adenine nucleotides (Thomas, P. J., Shenbagamurthi, P., Ysern, X., and Pedersen, P. L. (1991) Science 251, 555-557). A peptide lacking this critical residue, but otherwise corresponding to this crucial part of the protein, now also has been chemically synthesized and purified. This mutant peptide (P-66) exhibits a significant loss of β-sheet structure as compared with the wild type peptide (P-67). Furthermore, urea denaturation of peptide structure reveals that P-66 is less stable than P-67. Although under non-denaturing conditions both peptides bind adenine nucleotides with high affinity, the loss of structural stability is reflected in the binding function of the peptides. Thus, P-67, in contrast to P-66, retains a significant capacity for nucleotide binding in 4 M urea. These results suggest a model for impaired ΔPhe-508 CFTR function.

AB - Deletion of phenylalanine 508 (ΔPhe-508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes approximately 70% of all cases of cystic fibrosis. This residue lies in a region of the protein that we have synthesized chemically and shown to bind adenine nucleotides (Thomas, P. J., Shenbagamurthi, P., Ysern, X., and Pedersen, P. L. (1991) Science 251, 555-557). A peptide lacking this critical residue, but otherwise corresponding to this crucial part of the protein, now also has been chemically synthesized and purified. This mutant peptide (P-66) exhibits a significant loss of β-sheet structure as compared with the wild type peptide (P-67). Furthermore, urea denaturation of peptide structure reveals that P-66 is less stable than P-67. Although under non-denaturing conditions both peptides bind adenine nucleotides with high affinity, the loss of structural stability is reflected in the binding function of the peptides. Thus, P-67, in contrast to P-66, retains a significant capacity for nucleotide binding in 4 M urea. These results suggest a model for impaired ΔPhe-508 CFTR function.

UR - http://www.scopus.com/inward/record.url?scp=0026649584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026649584&partnerID=8YFLogxK

M3 - Article

VL - 267

SP - 5727

EP - 5730

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 9

ER -